Answers are grounded in this paper and cite their sources.
BACKGROUND: H. pylori eradication usually involves treatment with three or four drugs for at least 7 days. Possible advantages of short treatment regimens are better patient compliance and tolerability. and less adverse effects. Recently two reports have shown a cure rate of > 90% using a 4-day quadruple therapy. AIM: To confirm these data and to evaluate the efficacy and tolerability of 4-day quadruple therapy in a single centre. METHODS: Thirty-eight consecutive patients with non-ulcer dyspepsia or peptic ulcer disease, and proven H. pylori infection, received 4 days of quadruple therapy (bismuth, tetracycline, metronidazole, lansoprazole). At least 6 weeks after treatment, endoscopy was repeated with six biopsies of antrum and corpus for histology and culture. RESULTS: The intention-to-treat cure rate was 34/38 (89.5%, 95% CI: 79.7-99.2%). In the per protocol analysis the cure rate was 34/37 (91.9%, 95% CI: 83.1-100%). Primary metronidazole resistance was observed in two patients; both were cured. Metronidazole resistance induction was observed in one patient in whom therapy failed. The treatment was generally well tolerated. CONCLUSION: Routine use of 4-day quadruple anti-H. pylori treatment is effective and well tolerated.
No takes yet. Share an insight, caveat, or question.
Boer et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: